Lupus — technically lupus erythematosus — is an autoimmune disease in which the immune system attacks healthy tissue throughout the body. For veterans, lupus presents a unique and complex VA disability claims challenge: the disease is multi-systemic, highly variable in presentation, frequently misdiagnosed early in its course, and often not diagnosed until years after the triggering exposure or onset of symptoms during military service.
Veterans across all service eras can develop lupus, and it is particularly prevalent among female veterans — lupus disproportionately affects women, especially women of color. Veterans who served in environments with known immune-modulating exposures — Agent Orange, burn pits, chemical agent exposure, Gulf War deployment — may have additional service connection pathways.
This guide covers every aspect of lupus VA claims: the two primary diagnostic code families (SLE under DC 6350 and DLE under DC 7809), the regulatory schedules that govern each, the critical "residuals strategy" for claiming separate ratings for joint damage, kidney disease, hematological complications, and scarring, the Gulf War presumption pathway, and service connection strategies for veterans whose lupus developed after discharge.
There are two primary forms of lupus that VA recognizes:
Systemic lupus erythematosus (SLE) is a severe, multi-organ autoimmune disease. In SLE, the immune system generates autoantibodies (particularly anti-dsDNA and anti-Smith antibodies) that attack tissues throughout the body — causing inflammation in the kidneys, heart, lungs, brain, joints, skin, and blood cells simultaneously or in sequence. SLE is characterized by flares (periods of acute exacerbation) and remissions. During flares, veterans can experience extreme fatigue, joint pain, skin rashes (classically the butterfly/malar rash across the face), serositis, nephritis, neurological symptoms, and severe constitutional symptoms including fever and weight loss.
SLE is rated under DC 6350 in 38 CFR 4.88b (the Hemic and Lymphatic Systems schedule), with a maximum schedular rating of 100% during active exacerbations with multi-organ involvement.
Discoid lupus erythematosus (DLE) is primarily a chronic skin condition. While DLE can share some features with SLE — and approximately 5–10% of DLE patients may eventually develop SLE — DLE is typically limited to the skin, producing coin-shaped, scarring lesions predominantly on sun-exposed areas (face, scalp, neck, hands). DLE does not typically cause the systemic, multi-organ involvement that characterizes SLE.
DLE is rated under DC 7809 in 38 CFR 4.118 (the Skin Diseases schedule) based on the percentage of affected skin area. The rating potential for isolated DLE is lower than for SLE, though veterans with extensive scarring may qualify for significant ratings under the skin and scar schedules.
Under 38 CFR 4.88b, DC 6350, systemic lupus erythematosus is rated as follows:
| Rating | Criteria |
|---|---|
| 10% | Exacerbations of one or two symptoms of the condition (e.g., occasional joint pain, skin manifestations without systemic involvement) |
| 30% | Exacerbations of three or more symptoms, or chronic symptoms requiring continuous medication |
| 60% | Exacerbations of three or more symptoms, or constant treatment; more than one exacerbation per year affecting two or more organ systems |
| 100% | Acute exacerbations or chronic findings with severe constitutional symptoms (fever, weight loss, debility), OR with two or more major organ systems involved (nephritis, CNS involvement, myocarditis, pericarditis, pleuritis, anemia) — this is a minimum rate during active phases |
One of the most important — and underutilized — aspects of the DC 6350 rating is that the 100% rate is designated as a minimum rate during active, severe exacerbations. This means that when a veteran with SLE is experiencing an acute flare with multi-organ involvement meeting the criteria listed above, they are entitled to a 100% rating for the duration of that exacerbation period — regardless of their baseline rating during periods of remission or stability.
Veterans should document every hospitalization, every ER visit, and every acute flare carefully in their medical records. The cumulative impact of periodic 100% periods (triggering Chapter 35, CHAMPVA, and other 100% benefits during those periods) and the permanent rating representing baseline function should both be addressed in VA claims.
SLE is a fluctuating condition. VA must rate based on the average severity over the past 12 months, not solely on the day of the C&P exam. If a veteran has 3 significant flares per year with multi-organ involvement, but the C&P exam happens during a relative remission, the examiner must address the pattern of disease — not just the exam-day snapshot. Ensure your C&P examiner reviews your full medical records, including hospitalization records, nephrology records, and rheumatology notes, before conducting the exam.
Under DC 7809, discoid lupus erythematosus is rated under the general skin disability schedule at 38 CFR 4.118:
| Rating | Criteria |
|---|---|
| 10% | At least 5% but less than 20% of the entire body or at least 5% but less than 20% of exposed areas affected, or; intermittent systemic therapy such as corticosteroids or other immunosuppressive drugs required for a total duration of less than 6 weeks during the past 12 months |
| 30% | 20% to 40% of the entire body or 20% to 40% of exposed areas affected, or; systemic therapy such as corticosteroids or other immunosuppressive drugs required for a total duration of 6 weeks or more, but not constantly, during the past 12 months |
| 60% | More than 40% of the entire body or more than 40% of exposed areas affected, or; constant or near-constant systemic therapy required during the past 12 months |
DLE leaves permanent, disfiguring scarring — particularly on the face, scalp, and neck. These scars are separately ratable under the scar diagnostic codes (DC 7800–7805), which can add substantial additional ratings. A veteran with extensive discoid lupus scarring on the face can claim DC 7800 (Scars, disfiguring, of the head, face, or neck) for disfiguring facial scarring, in addition to the underlying DLE rating under DC 7809.
The single most impactful strategy for maximizing VA benefits from lupus is the residuals approach: claiming the underlying SLE/DLE at its appropriate schedular rate AND claiming each significant residual condition as a separately rated disability linked to the primary lupus diagnosis.
Under the secondary service connection doctrine, any condition that is caused by or aggravated beyond its natural progression by a service-connected condition is itself service-connected and separately ratable. For SLE, this opens the door to simultaneous separate ratings for lupus nephritis, lupus arthritis, lupus-related anemia, lupus-related cardiovascular complications, lupus-related neuropsychiatric conditions, and scarring.
Lupus arthritis — inflammation and damage to joints caused by SLE — is one of the most common and debilitating complications of systemic lupus. VA rates lupus arthritis under DC 5002 (Rheumatoid Arthritis and analogous conditions) or by analogy under DC 5099-5025 (arthritis, analogous to rheumatoid arthritis).
| Rating | DC 5002 Criteria |
|---|---|
| 20% | Two or more major joints or groups of minor joints with occasional incapacitating exacerbations |
| 40% | Two or more major joints or groups of minor joints, with weight loss and anemia productive of severe impairment of health, or; definite evidence of joint deformity and medical history of incapacitating exacerbation |
| 60% | Constitutional manifestations associated with active joint involvement, with weight loss, anemia, and marked limitation of activity |
| 100% | Incapacitating exacerbations occurring four or more times per year, or with total duration of at least 6 weeks |
Veterans with lupus arthritis should ensure their rheumatologist documents the number, location, and severity of joint involvement, any periods of incapacitating exacerbations, weight loss, anemia, and any joint deformity or erosion on imaging. See also VA disability rating for rheumatoid arthritis for analogous rating criteria.
Lupus nephritis — kidney inflammation and damage caused by SLE — is one of the most serious complications of systemic lupus and a major driver of VA disability ratings. It is rated under DC 7530 (Nephritis, chronic) in 38 CFR 4.115b:
| Rating | DC 7530 Criteria |
|---|---|
| 0% | Well-compensated; no significant systemic findings, disability, or incapacity |
| 30% | Constant albuminuria with some edema; or, definite decrease in kidney function; or, hypertension at least 40% disabling under DC 7101 |
| 60% | Persistent edema and albuminuria; BUN more than 40 mg%; or, creatinine more than 3 mg%; or, with hypertension at least 40% disabling |
| 80% | Pronounced uremia with frequent exacerbations; or, persistent edema, severe hypertension with BUN over 40 mg% |
| 100% | Nephrotic syndrome with persistent edema, hypoalbuminemia, and massive proteinuria; or, renal failure requiring dialysis |
Veterans with lupus nephritis should obtain nephrology records, kidney biopsy results, and laboratory values (BUN, creatinine, albumin, proteinuria levels) to support the appropriate rating level. Lupus nephritis requiring dialysis qualifies for a 100% VA rating under DC 7530. See VA disability rating for kidney disease secondary service connection.
Systemic lupus frequently causes hematological complications — anemia, thrombocytopenia (low platelets), and leukopenia (low white blood cells). These complications are separately ratable under the VA's hematological rating schedule:
Lupus-associated anemia can result from autoimmune hemolytic anemia (DC 7700), anemia secondary to chronic disease (DC 7703), or anemia from bone marrow suppression by immunosuppressive medications. Ratings range from 0% (well-compensated with normal hemoglobin) to 100% (requiring transfusions, with severe constitutional symptoms). DC 7700 (Hemolytic anemias) rates based on erythrocyte survival time and hemoglobin levels.
Immune thrombocytopenia (low platelet count) is rated under DC 7705. Ratings: 0% for mild; 30% for platelet count below 100,000 with spontaneous bruising; 70% for platelet count below 50,000 with petechiae and spontaneous bleeding; 100% for platelet count below 20,000 with severe bleeding complications.
Both DLE and SLE skin manifestations can leave permanent scarring. Scars are separately rated under the VA's scar diagnostic codes regardless of the underlying condition that caused them:
Under DC 7800, disfiguring scars of the head, face, or neck are rated at 10–80% based on the total area of facial disfigurement and the severity of distortion of features. Veterans with extensive discoid lupus lesions leaving disfiguring scars across the face, scalp, or neck should obtain a dermatology evaluation specifically for DC 7800 rating purposes — these scars are visible, permanent, and qualify for their own rating.
Under DC 7805 in 38 CFR 4.118, non-linear scars on areas other than head/face/neck are rated at 10% for at least 144 square cm; 20% for at least 576 sq cm; and 30% if the scar area is unstable or painful. Veterans with extensive body surface scarring from lupus skin involvement should ensure all affected areas are evaluated and measured during C&P exams.
Veterans who served in the Southwest Asia theater of operations (Gulf War, Operation Iraqi Freedom, Operation Enduring Freedom, and related deployments) have access to special presumptive service connection pathways under 38 CFR 3.317.
Under 38 CFR 3.317, Gulf War veterans may be service-connected for: (1) an undiagnosed illness, or (2) a medically unexplained chronic multisymptom illness (MUCMI) — including conditions such as functional gastrointestinal disorders, fatigue syndrome, and other chronic conditions without a well-established etiology. While SLE itself is a diagnosed condition with established pathology, Gulf War veterans developing autoimmune symptoms that initially present as an undiagnosed illness may establish service connection under this framework even before a formal SLE diagnosis is made.
The PACT Act (Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act) expanded presumptive service connection for veterans exposed to burn pits and other toxic exposures. While SLE is not currently on the PACT Act specific presumptive list, veterans with SLE who deployed to areas with documented burn pit exposure may pursue direct service connection with a nexus letter from a rheumatologist linking their autoimmune disease to toxic exposures. See Burn pit exposure VA claims guide and PACT Act presumptive conditions list.
Establishing service connection for lupus requires the same three elements as any VA claim: a current diagnosis, an in-service event or trigger, and a medical nexus linking the two. For lupus, the challenges are:
Lupus frequently takes years to diagnose — the ACR/EULAR classification criteria require documentation of multiple findings over time. A veteran who experienced joint pain, fatigue, and a skin rash during service may have been told simply to rest, given a non-specific diagnosis, or had their symptoms attributed to stress or other causes. The absence of a service-time diagnosis does not defeat service connection — what matters is that the condition was incurred or aggravated during service.
Direct service connection is available when a rheumatologist can opine that the veteran's lupus is at least as likely as not related to their military service — either because of a specific in-service trigger (viral illness, drug exposure, UV radiation exposure in certain duty stations), or because early symptoms began in service even if formal diagnosis came later. A nexus letter from a board-certified rheumatologist who has reviewed service treatment records is essential.
Under 38 CFR 3.303, veterans who experienced continuous symptoms from service through present can establish service connection through that continuity. Lay evidence — the veteran's own statement, buddy statements, family member statements attesting to ongoing symptoms since service — is legally recognized and can support this pathway.
REE Medical connects veterans with physicians experienced in VA disability evaluations. Get a free consultation to see if you qualify for a nexus letter linking your lupus or its residuals to service.
Check My Nexus Letter Options — Free →The following monthly compensation rates apply for 2026. For lupus veterans, the combined rating — including all residuals (nephritis, arthritis, anemia, mental health, scars) — determines monthly pay. All VA disability compensation is completely federal income tax-free.
| Combined Rating | Veteran Only | Veteran + Spouse | Veteran + Spouse + 1 Child |
|---|---|---|---|
| 10% | $175.51 | $175.51 | $175.51 |
| 20% | $346.95 | $346.95 | $346.95 |
| 30% | $537.42 | $601.58 | $650.40 |
| 60% | $1,395.93 | $1,506.27 | $1,598.84 |
| 70% | $1,759.43 | $1,885.65 | $1,993.41 |
| 80% | $2,044.89 | $2,186.42 | $2,309.52 |
| 90% | $2,297.96 | $2,454.80 | $2,593.25 |
| 100% | $3,737.85 | $4,063.63 | $4,244.05 |
Veterans with lupus who experience severe, active flares with multi-organ involvement during any period should receive the 100% minimum rate for those periods under DC 6350. Veterans whose overall combined rating (including all residuals) reaches 100% qualify for the maximum monthly compensation plus Permanent & Total (P&T) designation if the condition is unlikely to improve — unlocking CHAMPVA for dependents, Chapter 35 DEA education benefits, and DIC for surviving spouses.
Yes — through two pathways. First, DC 6350 explicitly assigns a 100% minimum rate during active, severe SLE exacerbations with multi-organ involvement. Second, the combined rating for SLE plus residuals (lupus nephritis at 60–100%, lupus arthritis at 40–100%, anemia at 30%, mental health at 30–70%, etc.) can mathematically produce a combined rating that rounds to 100%. Veterans with severe SLE who have been rated at 30–60% and haven't claimed residuals should request a claim review with a VA-accredited attorney to evaluate whether a combined 100% is achievable.
Lupus is not currently on the specific named presumptive lists for Agent Orange (38 CFR 3.309), Gulf War chronic disabilities (38 CFR 3.317), or the PACT Act. However, Gulf War veterans can pursue the MUCMI pathway, and veterans with documented exposure to specific chemicals or biological agents may pursue direct service connection with a strong nexus letter. Check the Agent Orange presumptive list and PACT Act presumptive list for the most current additions.
Documentation should include: rheumatology records showing diagnosis history and flare patterns; laboratory values (ANA, anti-dsDNA, complement levels, CBC, metabolic panel, urinalysis); nephrology records and kidney biopsy results if lupus nephritis is present; dermatology records documenting skin involvement and scarring; cardiology/pulmonology records for serositis or cardiovascular involvement; hospitalization records for acute flares; and a private rheumatologist opinion addressing rating-specific criteria (weeks of incapacitation, organ systems involved, treatment requirements).
Most lupus veterans are missing separate ratings for nephritis, arthritis, anemia, and mental health. Take our free screener to see what you may be owed.
Take the Free Eligibility Check →